Skip to main content
OpenTrials
Completed

NCT Number: NCT06771986

Soluble Advanced Glycation End Product (sRAGE) Levels

The aim of this study is to evaluate sRAGE levels in children with obesity and to determine the relationship between metabolic status and sRAGE levels in childhood obesity

Completed

Looking for future studies?

Notify Me

Key information

Age range

10 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kayseri City Hospital

Kayseri, 38080, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of Obesity BMI over 95th percentile BMI z-score over 2

Exclusion criteria

Primary hyperlipidemia Primary liver disease Hypothyroidism Diabetes

Treatment and study plan

observation

Other

sRAGE levels were studied in three different groups

Primary outcomes

  1. Evaluation of sRAGE levels in obese and healthy participants

    Time frame: From enrollment to the end of at 6 months

Sponsors and collaborators

Lead sponsor

Kayseri City Hospital

Other Gov

Registry information

Official study title

Soluble Advanced Glycation End Product (sRAGE) Levels in Childhood Obesity

Important dates

Study start
2023
Primary completion
2023
Study completion
2024
First posted
Jan 13, 2025
Registry last updated
Jan 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.